Page 7 of 12
1
The Journal of Organic Chemistry
MHz) δ (ppm): 7.63 (s, 1H), 7.57 (s,1H), 7.31 (t,
J= 7.2 Hz, 2H), 7.22 (t, J= 7.1 Hz, 1H), 7.15 (d,
J= 7.6Hz, 2H), 6.26 (s, 1H), 5.84 (d, J= 9.2 Hz,
tert-butyl
phenylpropyl)carbamate
(1-(1H-indazol-1-yl)-3-
5b
(6f)
following general protocol for azoles coupling.
was
obtained
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
1
1
(
(
(
H), 5.77 (m, 1H), 2.54-2.51 (m, 3H), 2.43-2.36 (m,
13
With 2g 31 mg, 88%, 3 28 mg, 79%, (Pet. Ether /
1
1
13
H), 1.42 (s, 9H). C{ H} NMR (CDCl
3
, 75MHz) δ
3
Ethyl acetate 3:1 as eluent) H{ C} NMR (CDCl , 300
ppm): 154.7, 140.3, 140.2, 130.0, 128.6 (2C), 128.5
2C), 126.3, 104.9, 80.3, 66.4, 36.0, 31.5, 28.3
3C).
MHz) δ(ppm): 8.14 (s br,1H), 7.79 (dd, J= 8.8 and
0.9 Hz, 1H), 7.72 (dt, J= 8.4 and 1.0 Hz, 1H),
7.38−7.20 (m, 4H), 7.16−7.11 (m, 3H), 6.49 (d br,J=
9.0 Hz,1H), 6.07 (m, 1H), 2.72−2.48 (m, 4H), 1.39
benzyl
(3-phenyl-1-(1H-pyrazol-1-
yl)propyl)carbamate (6b)5b was obtained following
13
1
3
(s, 9H). C{ H} NMR (CDCl , 75 MHz) δ(ppm): 154.7,
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
general protocol for azoles coupling. With 3 23 mg,
7
143.6, 141.3, 139.5, 132.5, 128.7(2C), 128.4 (2C),
126.6, 123.2, 122.6, 120.3, 110.8, 80.8, 62.4,
36.0,31.7, 28.2 (3C).
0%, (Pet. Ether / Ethyl acetate 4:1 as eluent)
13
1
H{ C} NMR (CDCl , 300 MHz) δ (ppm): 7.65 (s, 1H),
3
tert-butyl
(1-(1H-benzo[d]imidazol-1-yl)-3-
carbamate was obtained
(6g)5b
following general protocol for azoles coupling.
7
.60 (s, 1H), 7.40-7.20 (m, 8H), 7.14-7.11 (m, 2H),
.41 (d br, J = 9.2 Hz, 1H), 6.28 (s, 1H), 5.81 (t,
phenylpropyl)
6
J = 8.1 Hz, 1H), 5.16 (d, J = 12.1 Hz, 1H), 5.00
(d, J = 12.3 Hz, 1H), 2.63-2.32 (m, 4H). 13C{1H} NMR
With 2g 21 mg, 59%, (Pet. Ether / Ethyl acetate 1:1
1
13
as eluent) H{ C} NMR (CD
3
CN + D
.08 (s, 1H), 7.73-7.56 (m, 2H), 7.36-7.16 (m, 7H),
.56 (bs, 1H), 5.92 (q, J=7.1Hz, 1H), 2.78-2.40 (m,
2
O, 500 MHz) δ(ppm):
(CDCl , 75 MHz) δ (ppm): 155.5, 140.4, 140.1,
3
8
6
4
1
1
3
36.0, 130.1, 128.6 (2C), 128.5 (2C), 128.4 (2C),
28.2, 128.1, 126.3, 126.1, 105.0, 67.1, 66.8, 35.8,
1.4.
1
3
1
H), 1.36 (s, 9H),
3
C{ H} NMR (CDCl , 75 MHz)
δ(ppm): 154.7, 143.6,141.3, 139.5, 132.5, 128.7
tert-butyl
phenylpropyl) carbamate (6c)
(1-(3-methyl-1H-pyrazol-1-yl)-3-
5b
(
8
2C), 128.4 (2C), 126.6, 123.2, 122.6, 120.3, 110.8,
0.8, 62.4, 36.0, 31.7, 28.2 (3C).
was obtained
following general protocol for azoles coupling.
tert-butyl (1-(1H-pyrazol-1-yl)octyl)carbamate
With 2c 25 mg, 80%, 3 25 mg, 80%,(Pet. Ether / Ethyl
1
(6h)5b was obtained following general protocol for
azoles coupling. With 2g 29 mg, 99%, 3 21 mg, 71%,
(Pet. Ether / Ethyl acetate 4:1 as eluent) 1H{ C}
13
acetate 4:1 as eluent) H{ C} NMR (CDCl
3
, 300 MHz)
δ (ppm): 7.47−7.40 (m, 1H), 7.28−7.24 (m, 2H),
13
7
1
2
9
1
1
1
.20−7.15 (m, 1H), 7.12−7.09 (m, 2H), 5.98-5.96 (m,
H), 5.82-5.75 (m, 1H), 5.63-5.56 (m, 1H), 2.56-
.40 (m, 3H), 2.29 (s, 3H), 2.25 (m, 1H), 1.38 (s,
3
NMR (CDCl , 300 MHz) δ(ppm): 7.48 (s, 2H), 6.13 (s,
1H), 5.72(br s, 1H), 5.52 (br s, 1H), 2.12 (br s,
1H), 1.98 (br s, 1H), 1.33 (s, 9H), 1.28−1.08 (m,
1
3
1
3
H). C{ H} NMR (CDCl , 75 MHz) δ (ppm): 149.5,
1
3
1
3
10H), 0.78 (t, J= 6.7 Hz, 3H). C{ H} NMR (CDCl , 75
39.5, 130.9, 128.6 (2C), 128.5, 126.3, 104.9,
04.5, 66.3, 62.5, 36.1, 31.6, 28.4 (3C), 13.9,
0.8;
MHz) δ(ppm): 154.8, 140.0, 129.6, 104.7, 80.2,
67.2, 34.7, 31.6, 29.1, 29.0, 29.0, 28.3 (×3),
2
5.3, 22.5, 14.0;
tert-butyl
tert-butyl (1-(3,5-dimethyl-1H-pyrazol-1-yl)-3-
b
(1-(3,5-dimethyl-1H-pyrazol-1-
5
phenylpropyl) carbamate (6d) was obtained
following general protocol for azoles coupling.
yl)octyl) carbamate (6i)5b was obtained following
general protocol for azoles coupling. With 3 26 mg,
8
With 2c 32 mg, 97%, 3 25 mg, 76%, (Pet. Ether /
0%, (Pet. Ether / Ethyl acetate 4:1 as eluent)
1
13
3
Ethyl acetate 4:1 as eluent) H{ C} NMR (CDCl , 300
1
13
H{ C} NMR (CDCl
3
, 300MHz) δ (ppm): 5.74 (s, 1H),
.71−5.59 (m, 2H), 2.35 (s, 3H), 2.23(s, 3H),
.16−1.88 (m, 2H), 1.41 (s, 9H), 1.34−0.99 (m, 10H),
MHz) δ(ppm): 7.32−7.13 (m, 5H), 6.10 (d br, J= 9.2
Hz, 1H), 5.77 (s, 1H), 5.70 (m, 1H), 2.52−2.33 (m,
4
5
2
0
1
3
1
H), 2.27(s, 3H), 2.24 (s, 3H), 1.42 (s, 9H). C{ H}
13
1
3
.87 (t, J= 6.7 Hz, 3H). C{{ H} NMR (CDCl , 75 MHz)
NMR (CDCl , 75 MHz) δ(ppm): 154.8, 148.4, 140.7,
3
δ (ppm): 154.8,148.2, 134.4, 104.4, 79.8, 62.8,
139.6, 128.5 (2C), 128.4 (2C), 126.1, 104.7, 79.0,
62.2, 36.4, 31.5, 28.3 (3C), 13.7, 10.7;
3
1
5.3, 31.6, 29.0, 28.7, 28.2 (3C), 25.2, 22.5, 13.9,
3.6, 10.7;
tert-butyl (2-methyl-1-(1H-pyrazol-1-yl)propyl)
tert-butyl (1-(4-nitro-1H-pyrazol-1-yl)-3-
(6e)5b
phenylpropyl) carbamate was obtained
following general protocol for azoles coupling.
carbamate (6j)5b was obtained following general
protocol for azoles coupling. With 2c 20 mg, 84%, 3
8 mg, 75%, (Pet. Ether / Ethyl acetate 4:1 as
With 3 22 mg, 63%, (Pet. Ether / Ethyl acetate 4:1
1
1
13
3
as eluent) H{ C} NMR (CDCl , 300 MHz) δ(ppm): 8.29
1
13
eluent) H{ C} NMR (CDCl
3
, 300 MHz) δ(ppm): 7.55
(s br, 1H), 8.15 (s, 1H), 7.36−7.23 (m, 3H),
7.16−7.13 (m, 2H), 5.73−5.57 (m, 2H), 2.67−2.32 (m,
4
(
(
(
s, 1H),7.51 (s, 1H), 6.21 (s, 1H), 5.52 (d, J= 7.7
Hz, 1H), 5.37 (t, J= 9.0 Hz,1H), 2.38 (h, J= 6.5
Hz, 1H), 1.40 (s, 9H), 1.06 (d, J= 6.6 Hz, 3H), 0.70
13
1
3
H), 1.44 (s, 9H). C{ H} NMR (CDCl , 75 MHz) δ
ppm):154.3, 139.3, 136.4, 135.3, 128.8 (2C), 128.3
2C), 126.7 (2C), 81.4, 68.2, 35.1, 31.3, 28.2 (3C).
1
3
1
(
3
d, J= 6.6 Hz, 3H). C{ H} NMR (CDCl , 75 MHz)
ACS Paragon Plus Environment